Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.
Eric Ezan
Advertisement
Articles by Eric Ezan
Advertisement
Latest Updated Articles
Bioanalysis of recombinant proteins by mass spectrometryPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Standardizing Operations to Meet Global Sustainability and Resilience Goals
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
4
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
5
